Addiction & Substance Use

In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

10 keys to understanding the science of cannabinoids.

Manufactured fentanyl is a major cause of overdoses for opioids and nonopiods. Can a vaccine immunize against overdose?

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

The potential role of eye movement desensitization and reprocessing.

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.

Yes, we need better crisis management, but what we really need is better crisis prevention.

The enduring racial gap in the opiate addiction rate stems largely from racist 19th-century medical beliefs about Black bodies, coupled with substandard medical care provided to Black Civil War troops.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.

How can understanding the opioid crisis in Canada inform strategies in the United States?

Healthy lungs are at risk—what can you do as a clinician to help patients quit vaping?

Cannabis is prescribed as a treatment for autism in 14 states. Is it the wonder drug patients and families have been waiting for?

There's a long history of psychedelics...

How can mental health professionals promote a true community of immunity?

As all eyes were on the pandemic, another surge simmered below the surface.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.

Although college drinking develops into an addiction, overconsumption and especially binge drinking patterns are often preludes to alcohol use disorder, with approximately 1 in 10 students meeting criteria for AUD.

A recent study tested a new digital therapeutic for effectiveness on both substance abuse and depression.

Government funding for the drug addiction crisis is on the way.

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.

The sharply decreasing perception of risk and easy accessibility of cannabis has many patients turning towards it, despite the potential negative effects.

As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.